Concepedia

Rainer Kühn

RK

Statistics

Publications

63

Citations

6.7K

H-Index

43

Active since

1994

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of the Basque Country

Centre National de la Recherche Scientifique

Max Planck Institute for Brain Research

Rainer Kühn is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and neuroscience.

Top concepts

Publications per year

1994–2018

63

Publications

63

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

F. Gasparini, Kurt Lingenhöhl, Natacha Stoehr et al. · Neuropharmacology · 1999 · 720 citations

, , +7

LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice

Martin C. Herzig, Carine Kolly, Elke Persohn et al. · Human Molecular Genetics · 2011 · 361 citations · Full text

, , +20

Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

E Tatarczyńska, Aleksandra Kłodzińska, E Chojnacka-Wójcik et al. · British Journal of Pharmacology · 2001 · 308 citations · Full text

C-Terminal Interaction Is Essential for Surface Trafficking But Not for Heteromeric Assembly of GABA<sub>B</sub>Receptors

Adriana Pagano, Giorgio Rovelli, Johannes Mosbacher et al. · Journal of Neuroscience · 2001 · 305 citations · Full text

, , +22

The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors

Adriana Pagano, Doris Rüegg, Stephane Litschig et al. · Journal of Biological Chemistry · 2000 · 267 citations · Full text

1–5 of 63